Fresh Tracks Therapeutics Q3 EPS $0.32 Up From $(2.07) YoY, Sales $7.99M Up From $486.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Fresh Tracks Therapeutics (FRTX) reported a significant increase in Q3 earnings to $0.32 per share, up from a loss of $(2.07) per share year-over-year. Sales also saw a substantial rise to $7.99M, a 1.54K percent increase from $486.00K in the same quarter last year.
November 13, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Fresh Tracks Therapeutics reported a strong Q3 with EPS at $0.32, up from a loss, and sales increasing to $7.99M from $486K YoY.
The substantial increase in both earnings per share and sales indicates a strong financial performance for Fresh Tracks Therapeutics, which is likely to positively influence investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100